A new approach to gene therapy using Sleeping Beauty to genetically modify clinical-grade T cells to target CD19
Article first published online: 13 DEC 2013
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
Special Issue: Adoptive Immunotherapy for Cancer
Volume 257, Issue 1, pages 181–190, January 2014
How to Cite
Singh, H., Huls, H., Kebriaei, P. and Cooper, L. J. N. (2014), A new approach to gene therapy using Sleeping Beauty to genetically modify clinical-grade T cells to target CD19. Immunological Reviews, 257: 181–190. doi: 10.1111/imr.12137
- Issue published online: 13 DEC 2013
- Article first published online: 13 DEC 2013
Options for accessing this content:
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.